We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Update on New Adverse Events for Breast Implants
FDA Releases Update on New Adverse Events for Breast Implants
The FDA issued an update on adverse events related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and breast implant illness.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor